Staar Surgical (STAA) Return on Capital Employed (2011 - 2026)
Staar Surgical's (STAA) quarterly Return on Capital Employed came in at 6.75% in Q2 2026, up 3509.0% YoY from 0.19% in Q2 2025, and up 71.65% on a QoQ basis from 23.79% in Q1 2026.
Staar Surgical (STAA) Return on Capital Employed (2011 - 2026) Analysis & Trends
Staar Surgical (STAA) has 16 years of Return on Capital Employed data on file, last reported at 6.75% in Q2 2026.
- Quarterly Return on Capital Employed rose 3509.0% year-over-year to 6.75% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 6.75% (up 3509.0% YoY) and the FY2026 annual result came in at 57.72%, down 7644.0% from the prior year.
- Return on Capital Employed grew to 6.75% in Q2 2026, from 23.79% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 29.94% in Q4 2022 to a low of 41.84% in Q1 2025.
- A 5-year average of 1.65% and a median of 6.03% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2025 — Return on Capital Employed plunged 5428 bps — and 2026, when it soared 3509 bps.
- Tracing STAA's Return on Capital Employed over 5 years: stood at 29.94% in 2022, then slumped by 45 bps to 16.33% in 2023, then sank by 139 bps to 6.3% in 2024, then plunged by 298 bps to 25.11% in 2025, then surged by 73 bps to 6.75% in 2026.
- The last three Return on Capital Employed figures came in at 6.75% (Q2 2026), 23.79% (Q1 2026), and 25.11% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.28% |
| 10 | Staar Surgical | 1.16 Bn | 979.42 Mn | 69.73 Mn | 3.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 3.52% |
| Apr 3, 2026 | -6.75% |
| Jan 2, 2026 | -23.79% |
| Sep 26, 2025 | -25.11% |
| Jun 27, 2025 | -28.22% |
| Mar 28, 2025 | -41.84% |
| Dec 27, 2024 | -6.30% |
| Sep 27, 2024 | 5.60% |
| Jun 28, 2024 | 6.03% |
| Mar 29, 2024 | 12.44% |
| Dec 29, 2023 | 16.33% |
| Sep 29, 2023 | 4.67% |
| Jun 30, 2023 | 6.94% |
| Mar 31, 2023 | 21.15% |
| Dec 30, 2022 | 29.94% |
| Sep 30, 2022 | 14.77% |
| Jul 1, 2022 | 13.99% |
| Apr 1, 2022 | 28.12% |
| Dec 31, 2021 | 29.20% |
| Oct 1, 2021 | 8.84% |